Mode
Text Size
Log in / Sign up

Tight glycemic targets in GDM reduce LGA births and cesarean rates but increase insulin useCan stricter blood sugar targets during pregnancy lead to healthier births?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that tight GDM targets may reduce LGA births but increase insulin requirements.

This single-center, open-label randomized controlled trial enrolled 650 women with gestational diabetes mellitus (singleton pregnancies, 12-31 weeks' gestation), with 626 (96.3%) providing primary outcome data. Participants were assigned to tight glycemic targets (fasting <5.1 mmol/L, 1-hour postprandial <7.0 mmol/L) or less tight targets (fasting <5.3 mmol/L, postprandial <7.8 mmol/L). The primary outcome was incidence of large-for-gestational-age infants.

The tight-target group had a significantly lower incidence of LGA infants (19.2% vs 26.5%; adjusted relative risk 0.61; 95% CI 0.42-0.89; p=0.010). Cesarean delivery rates were also lower (23% vs 29.9%; aRR 0.63; p=0.012), and gestational weight gain was reduced (10.1 kg vs 10.7 kg; p=0.006). However, insulin use was higher in the tight-target group (32.6% vs 21.6%; aRR 1.67; p=0.005).

Safety data showed serious complications were low and comparable between groups. Maternal hypoglycemia rates were also low and comparable. The study did not report long-term outcomes for mothers or infants, quality of life measures, or cost-effectiveness.

This intention-to-treat analysis from a single-center RCT suggests tighter glycemic control may reduce some adverse perinatal outcomes but increases the need for insulin therapy. The open-label design and lack of long-term data limit definitive conclusions about clinical implementation.

When a woman develops diabetes during pregnancy, managing her blood sugar is crucial for her health and her baby's. A new study asked a practical question: do stricter blood sugar targets lead to better outcomes than more relaxed ones? The trial involved 650 women with gestational diabetes and compared two different approaches to managing their glucose levels.

The results suggest that aiming for tighter control made a difference. Women in the stricter-target group were less likely to have a baby that was large for its gestational age—a condition linked to birth complications. They also had lower rates of cesarean delivery and gained less weight during pregnancy. However, this stricter approach came with a clear trade-off: significantly more women in this group needed insulin therapy to meet those tighter goals.

It's important to understand what this study does and doesn't tell us. The benefits for the baby's size and birth method are promising, and serious complications were low and similar in both groups. But the trial was conducted at a single medical center and was 'open-label,' meaning everyone knew which treatment they were getting, which can sometimes influence results. The study also didn't look at long-term health for mothers or babies, or how this approach affected women's daily quality of life. The increased need for insulin is a real consideration, as it means more medication and monitoring for many.

What this means for you:
Tighter blood sugar control in pregnancy may help babies and moms, but often requires more insulin.

Study Details

Study typeRct
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
AIMS: To determine if tight glycemic control in gestational diabetes mellitus (GDM) reduces adverse outcomes compared to less tight targets. METHODS: In a single-center, open-label randomized controlled trial, 650 women with GDM (singleton pregnancies, 12-31 weeks' gestation) were randomized to tight (fasting < 5.1 mmol/L, 1-h postprandial < 7.0 mmol/L) or less tight (fasting < 5.3 mmol/L, postprandial < 7.8 mmol/L) targets. The primary outcome was the incidence of large-for-gestational-age (LGA) infants. Secondary outcomes included measures of maternal and neonatal health, analyzed by intention-to-treat. RESULTS: Of 650 enrolled women, 626 (96.3%) completed the trial with primary outcome data. The tight-target group had a lower incidence of LGA (19.2% vs. 26.5%; adjusted relative risk (aRR) 0.61, 95%CI 0.42-0.89; p = 0.010), lower cesarean rates (23% vs. 29.9%; aRR 0.63; p = 0.012), and reduced gestational weight gain (10.1 vs. 10.7 kg; p = 0.006). Insulin use was higher with tight targets (32.6% vs. 21.6%; aRR 1.67; p = 0.005). Serious complications and maternal hypoglycemia rates were low and comparable. CONCLUSION: Tight glycemic targets in GDM lower the risk of LGA births, cesarean delivery, and excess maternal weight gain without increasing severe adverse events, though they necessitate more frequent insulin therapy.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.